Atara Biotherapeutics, Inc.
Hedge Funds Holdings
Last updated:
Atara Biotherapeutics, Inc.‘s stocks are currently a part of 76 hedge funds’ portfolios, which represents 53.26% of the total amount of its stocks outstanding. This makes up a total of 54.32M shares of Atara Biotherapeutics, Inc.. Compared to the previous quarter, the number fell by -44.20% or -43.02M shares fewer. As for the holding position changes, 44.74% (34) of current hedge fund investors increased the number of shares held, 30.26% (23) of current holders sold a part of the shares held, and 21.05% (16) closed the holdings completely. 3 hedge funds are new holders of Atara Biotherapeutics, Inc. stock in Q1 2023, it is 3.95% of total holders.
Hedge funds holding Atara Biotherapeutics (Q2 2018 – Q1 2023)
| Q2 2018 | 124 |
|---|---|
| Q3 2018 | 115 |
| Q4 2018 | 121 |
| Q1 2019 | 120 |
| Q2 2019 | 116 |
| Q3 2019 | 112 |
| Q4 2019 | 117 |
| Q1 2020 | 109 |
| Q2 2020 | 122 |
| Q3 2020 | 140 |
| Q4 2020 | 147 |
| Q1 2021 | 150 |
| Q2 2021 | 144 |
| Q3 2021 | 139 |
| Q4 2021 | 139 |
| Q1 2022 | 139 |
| Q2 2022 | 132 |
| Q3 2022 | 149 |
| Q4 2022 | 139 |
| Q1 2023 | 76 |
Hedge funds changes in Atara Biotherapeutics positions (Q2 2018 – Q1 2023)
| Q2 2018 | 20 | 60 | 29 | 10 | 5 |
|---|---|---|---|---|---|
| Q3 2018 | 13 | 43 | 29 | 22 | 8 |
| Q4 2018 | 20 | 42 | 40 | 13 | 6 |
| Q1 2019 | 15 | 52 | 39 | 16 | -2 |
| Q2 2019 | 23 | 53 | 23 | 25 | -8 |
| Q3 2019 | 22 | 60 | 16 | 26 | -12 |
| Q4 2019 | 20 | 45 | 29 | 15 | 8 |
| Q1 2020 | 20 | 48 | 23 | 25 | -7 |
| Q2 2020 | 32 | 61 | 19 | 19 | -9 |
| Q3 2020 | 32 | 53 | 37 | 14 | 4 |
| Q4 2020 | 27 | 59 | 44 | 20 | -3 |
| Q1 2021 | 23 | 62 | 43 | 19 | 3 |
| Q2 2021 | 18 | 48 | 53 | 24 | 1 |
| Q3 2021 | 15 | 53 | 46 | 19 | 6 |
| Q4 2021 | 16 | 52 | 47 | 16 | 8 |
| Q1 2022 | 21 | 52 | 43 | 20 | 3 |
| Q2 2022 | 20 | 48 | 40 | 23 | 1 |
| Q3 2022 | 36 | 63 | 29 | 21 | 0 |
| Q4 2022 | 17 | 48 | 53 | 23 | -2 |
| Q1 2023 | 3 | 34 | 23 | 16 | 0 |
Hedge funds changes in Atara Biotherapeutics stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 14,601,000 | 12,340,000 |
|---|---|---|
| Q3 2018 | 3,534,000 | 4,962,000 |
| Q4 2018 | 4,584,000 | 1,504,000 |
| Q1 2019 | 7,577,000 | 2,162,000 |
| Q2 2019 | 4,181,000 | 1,557,000 |
| Q3 2019 | 2,836,000 | 1,246,000 |
| Q4 2019 | 1,221,000 | 2,130,000 |
| Q1 2020 | 717,000 | 299,000 |
| Q2 2020 | 1,502,000 | 746,000 |
| Q3 2020 | 1,761,000 | 778,000 |
| Q4 2020 | 1,760,000 | 1,819,000 |
| Q1 2021 | 1,064,000 | 363,000 |
| Q2 2021 | 426,000 | 436,000 |
| Q3 2021 | 677,000 | 401,000 |
| Q4 2021 | 1,009,000 | 261,000 |
| Q1 2022 | 1,550,000 | 109,000 |
| Q2 2022 | 2,323,475 | 407,000 |
| Q3 2022 | 114,000 | 342,000 |
| Q4 2022 | 5,132,544 | 25,584 |
| Q1 2023 | 1,818,617,000 | 3,247,000 |